Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Omyla-Staszewska
J. Omyla-Staszewska
Medicine
Physical therapy
Colorectal cancer
Internal medicine
Irinotecan
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efFicacy and safely or idelalisib (GS-1101) in combination with bendamustine and Minimal) for previously treated chronic lymphocytic leukemia (CLL).
2014
Journal of Clinical Oncology
Herbert Eradat
Tadeusz Robak
Julio Delgado
Anna Schuh
Alexander S. Pristupa
J. Omyla-Staszewska
J C Barrlentos
Charles M. Farber
Donald Macdonald
Abraham Jacob
Jeffrey P. Sharman
Javier Loscertales
Jennifer R. Brown
B Colffier
Paolo Ghia
Andrew D. Zelenetz
Shelley Evans
Thomas M. Jahn
Michael Hallek
Peter Hillmen
Show All
Source
Cite
Save
Citations (0)
Long-term follow-up of efficacy of irinotecan-based chemotherapy in poor-risk patients suffering from metastatic colorectal cancer.
2010
Journal of Clinical Oncology
A. Krzyszton
M. Magon
J. Omyla-Staszewska
A. Asendrych-Wozniak
A. Deptala
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of irinotecan-based chemotherapy in poor risk patients suffering from metastatic colorectal cancer
2007
Journal of Clinical Oncology
A. Deptala
M. Magon
J. Omyla-Staszewska
Alicja Asendrych
M. Paluszewska
Show All
Source
Cite
Save
Citations (0)
1